PLXP logo

PLx Pharma (PLXP) Cash From Operations

Annual CFO

-$32.12 M
-$19.88 M-162.34%

December 31, 2021

Summary

Performance

1-Year Change

-162.34%

3-Year Change

-238.11%

5-Year Change

-141.37%

15-Year Change

-141.37%

PLXP Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.54 M

3-Year Low

-$32.12 M
PLXP annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
PLXP previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
PLXP next annual earnings announcement has not yet been scheduled

OtherPLXPcash flowmetrics:

Annual CFI

$95.00 K
PLXP annual cash flow from investing activities is $95.00 thousand

Annual CFF

$78.97 M
PLXP annual cash flow from financing activities is $78.97 million

Annual FCF

-$32.12 M
PLXP annual free cash flow is -$32.12 million

Annual CAPEX

-
PLXP annual capital expenditures value is unknown

Quarterly CFO

-$10.98 M
+$7.12 M+39.32%

September 30, 2022

Summary

Performance

3-Month Change

+39.32%

1-Year Change

-22.05%

3-Year Change

-247.97%

5-Year Change

-554.31%

PLXP Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$3.94 M
PLXP quarterly cash flow from operations is currently -378.67% below its historical high of $3.94 million

3-Year Low

-$18.10 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
PLXP previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
PLXP next earnings announcement has not yet been scheduled

OtherPLXPcash flowmetrics:

Quarterly CFI

$0.00
PLXP quarterly cash flow from investing activities is $0.00

Quarterly CFF

$1.09 M
PLXP quarterly cash flow from financing activities is $1.09 million

Quarterly FCF

-$10.98 M
PLXP quarterly free cash flow is -$10.98 million

Quarterly CAPEX

-
PLXP quarterly capital expenditures value is unknown

TTM CFO

-$59.34 M
-$1.98 M-3.46%

September 30, 2022

Summary

Performance

3-Month Change

-3.46%

1-Year Change

-178.88%

3-Year Change

-368.71%

5-Year Change

-368.71%

PLXP TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.14 M
PLXP TTM cash flow from operations is currently -5324.53% below its historical high of $1.14 million

3-Year Low

-$59.34 M
PLXP TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
PLXP previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
PLXP next earnings announcement has not yet been scheduled

OtherPLXPcash flowmetrics:

TTM CFI

$1000.00
PLXP TTM cash flow from investing activities is $1000.00

TTM CFF

$2.61 M
PLXP TTM cash flow from financing activities is $2.61 million

TTM FCF

-$59.34 M
PLXP TTM free cash flow is -$59.34 million

TTM CAPEX

-
PLXP TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PLXP Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-162.3%-22.1%-178.9%
3 y3 years-238.1%-248.0%-368.7%
5 y5 years-141.4%-554.3%-368.7%

PLXP Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+64.8%+84.7%at low
5 y5-year+162.3%at low+335.9%+64.8%+384.6%at low
alltimeall time+1980.5%at low-378.7%+64.8%-5324.5%at low

PLx Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2022
-
-$10.98 M(-39.3%)
-$59.34 M(+3.5%)
Jun 2022
-
-$18.10 M(+7.1%)
-$57.35 M(+28.2%)
Mar 2022
-
-$16.89 M(+26.4%)
-$44.73 M(+39.3%)
Dec 2021
-$32.12 M(+162.3%)
-$13.36 M(+48.5%)
-$32.12 M(+51.0%)
Sep 2021
-
-$9.00 M(+64.3%)
-$21.28 M(+38.1%)
Jun 2021
-
-$5.48 M(+27.9%)
-$15.40 M(+20.8%)
Mar 2021
-
-$4.28 M(+70.0%)
-$12.75 M(+4.1%)
Dec 2020
-$12.24 M(-3.3%)
-$2.52 M(-19.3%)
-$12.24 M(-8.4%)
Sep 2020
-
-$3.12 M(+10.5%)
-$13.36 M(-0.2%)
Jun 2020
-
-$2.83 M(-25.1%)
-$13.39 M(+1.8%)
Mar 2020
-
-$3.77 M(+3.8%)
-$13.16 M(+4.0%)
Dec 2019
-$12.66 M(+33.3%)
-$3.64 M(+15.2%)
-$12.66 M(+11.9%)
Sep 2019
-
-$3.16 M(+21.7%)
-$11.31 M(+18.4%)
Jun 2019
-
-$2.59 M(-20.8%)
-$9.55 M(+5.5%)
Mar 2019
-
-$3.27 M(+43.1%)
-$9.05 M(-4.7%)
Dec 2018
-$9.50 M(-28.6%)
-$2.29 M(+63.6%)
-$9.50 M(-26.4%)
Sep 2018
-
-$1.40 M(-33.3%)
-$12.91 M(-2.1%)
Jun 2018
-
-$2.10 M(-43.7%)
-$13.19 M(-11.5%)
Mar 2018
-
-$3.72 M(-34.7%)
-$14.90 M(+11.9%)
Dec 2017
-$13.31 M
-$5.70 M(+239.3%)
-$13.31 M(+66.0%)
DateAnnualQuarterlyTTM
Sep 2017
-
-$1.68 M(-55.9%)
-$8.01 M(+21.3%)
Jun 2017
-
-$3.80 M(+78.6%)
-$6.61 M(-681.9%)
Mar 2017
-
-$2.13 M(+428.4%)
$1.14 M(-162.7%)
Dec 2016
-$1.81 M(-87.6%)
-$403.00 K(+47.7%)
-$1.81 M(-66.3%)
Sep 2016
-
-$272.80 K(-106.9%)
-$5.38 M(-43.4%)
Jun 2016
-
$3.94 M(-177.7%)
-$9.49 M(-42.9%)
Mar 2016
-
-$5.08 M(+27.8%)
-$16.63 M(+13.9%)
Dec 2015
-$14.59 M(+29.4%)
-$3.97 M(-9.5%)
-$14.59 M(+8.3%)
Sep 2015
-
-$4.39 M(+37.6%)
-$13.47 M(+13.8%)
Jun 2015
-
-$3.19 M(+4.9%)
-$11.84 M(-1.9%)
Mar 2015
-
-$3.04 M(+6.6%)
-$12.07 M(+7.0%)
Dec 2014
-$11.28 M(+413.9%)
-$2.85 M(+3.7%)
-$11.28 M(+21.5%)
Sep 2014
-
-$2.75 M(-19.6%)
-$9.28 M(+25.9%)
Jun 2014
-
-$3.42 M(+52.0%)
-$7.37 M(+76.2%)
Mar 2014
-
-$2.25 M(+162.5%)
-$4.18 M(+90.7%)
Dec 2013
-$2.19 M(+42.1%)
-$857.50 K(+1.7%)
-$2.19 M(+64.1%)
Sep 2013
-
-$842.90 K(+263.2%)
-$1.34 M(+170.7%)
Jun 2013
-
-$232.10 K(-11.3%)
-$493.90 K(+88.7%)
Mar 2013
-
-$261.80 K
-$261.80 K
Dec 2012
-$1.54 M
-
-

FAQ

  • What is PLx Pharma annual cash flow from operations?
  • What is the all time high annual CFO for PLx Pharma?
  • What is PLx Pharma annual CFO year-on-year change?
  • What is PLx Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for PLx Pharma?
  • What is PLx Pharma quarterly CFO year-on-year change?
  • What is PLx Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for PLx Pharma?
  • What is PLx Pharma TTM CFO year-on-year change?

What is PLx Pharma annual cash flow from operations?

The current annual CFO of PLXP is -$32.12 M

What is the all time high annual CFO for PLx Pharma?

PLx Pharma all-time high annual cash flow from operations is -$1.54 M

What is PLx Pharma annual CFO year-on-year change?

Over the past year, PLXP annual cash flow from operations has changed by -$19.88 M (-162.34%)

What is PLx Pharma quarterly cash flow from operations?

The current quarterly CFO of PLXP is -$10.98 M

What is the all time high quarterly CFO for PLx Pharma?

PLx Pharma all-time high quarterly cash flow from operations is $3.94 M

What is PLx Pharma quarterly CFO year-on-year change?

Over the past year, PLXP quarterly cash flow from operations has changed by -$1.98 M (-22.05%)

What is PLx Pharma TTM cash flow from operations?

The current TTM CFO of PLXP is -$59.34 M

What is the all time high TTM CFO for PLx Pharma?

PLx Pharma all-time high TTM cash flow from operations is $1.14 M

What is PLx Pharma TTM CFO year-on-year change?

Over the past year, PLXP TTM cash flow from operations has changed by -$38.06 M (-178.88%)